← Leaderboards
Roger J Laham
Harvard University (Medical School)
$877,877
Attributed
$877,877
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$877,877 · 5
By mechanism
P50$877,360 · 1
M01$517 · 4
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- David C Christiani$98,689,404
- Gloria Y Yeh$13,084,500
- R. Paul Johnson$56,310,063
- John Blenis$37,183,011
- Timothy James O'Farrell$13,680,191
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationAngiogenesisClinical Trial Phase IFibroblast Growth FactorMyocardial Ischemia /HypoxiaCoronary DisorderHeart FunctionSwineLaboratory MouseMagnetic Resonance ImagingPericardiumDrug Administration RoutesLaser TherapyDrug Delivery SystemsCardiovascular Disorder ChemotherapyIntraluminal AngioplastyAngina PectorisBiomedical Equipment SafetyBiosensor DeviceDosageDrug Screening /EvaluationHeart Disorder Chemotherapy
Grant awards (9)
Exercise and Placebo$517
M01 · FY2004 · RR
Clinical trials of local percutaneous delivery of bFGF in CAD$219,340
P50 · FY2002 · HL
RFGF 2 IN SUBJECTS W/ ADVANCED CORONARY HEART DISEASE$0
M01 · FY2002 · RR
BIOSENSE DMR SAFETY &FEASIBILITY INVESTIGATIONAL TRIAL$0
M01 · FY2002 · RR
FIBROBLAST GROWTH FACTOR 2 IN CORONARY ARTERY DISEASE$0
M01 · FY2002 · RR
Clinical trials of local percutaneous delivery of bFGF in CAD$219,340
P50 · FY2001 · HL
Clinical trials of local percutaneous delivery of bFGF in CAD$219,340
P50 · FY2001 · HL
BIOSENSE DMR SAFETY &FEASIBILITY INVESTIGATIONAL TRIAL$0
M01 · FY2001 · RR
Clinical trials of local percutaneous delivery of bFGF in CAD$219,340
P50 · FY2000 · HL